Antigen and Lymphopenia-Driven Donor T Cells Are Differentially Diminished by Post-Transplantation Administration of Cyclophosphamide after Hematopoietic Cell Transplantation
Keywords: Allogeneic-hematopoietic stem cell transplantation (HSCT); Graft-versus-host disease (GVHD); Lymphopenia-induced proliferation; Alkylating agent; Post-transplantation cyclophosphamide; Myeloablative conditioning